Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
11.18
-0.46 (-3.95%)
Nov 19, 2026, 4:00 PM EST - Market closed
Mesoblast Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Mesoblast stock has a consensus rating of "Buy" and an average price target of $37. The average 1-year stock price forecast is 230.95% higher than the current stock price, while the lowest is $35 (+213.06%) and the highest is $39 (+248.84%).
Price Target: $37 (+230.95%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Sep 25, 2026.
Analyst Ratings
The average analyst rating for Mesoblast stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $35 | Buy | Maintains | $35 | +213.06% | Sep 25, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $35 → $39 | Buy | Reiterates | $35 → $39 | +248.84% | Aug 27, 2026 |
Financial Forecast
Revenue This Year
169.22M
from 120.25M
Increased by 40.72%
Revenue Next Year
258.95M
from 169.22M
Increased by 53.03%
EPS This Year
-0.03
from -0.04
EPS Next Year
0.01
from -0.03
EPS and Forward PE are based on non-GAAP adjusted numbers.